An update from Novo Nordisk ( ($NVO) ) is now available. Novo Nordisk reported full-year 2025 results on 3 February 2026, with sales rising 6% in D......

Novo Nordisk ( ($NVO) ) just unveiled an update. On 3 February 2026, Novo Nordisk reported that in 2025 its sales rose 10% and operating profit inc......

Novo Nordisk ( ($NVO) ) has shared an announcement. On 2 February 2026, Novo Nordisk reported headline phase 3 results from its REIMAGINE 2 trial s......

An announcement from Novacyt ( ($FR:ALNOV) ) is now available. Novacyt has reported its latest monthly activity under a French-law governed liquidi......

An announcement from Novacyt ( ($FR:ALNOV) ) is now available. Novacyt has reported its latest monthly activity under a French-law governed liquidi......

In a report released today, Matthew Weston from UBS maintained a Hold rating on Novo Nordisk, with a price target of DKK390.00. According to TipRan......

In a report released on January 30, David Evans from Kepler Capital maintained a Buy rating on Novo Nordisk, with a price target of DKK430.00. The ......

Novo Nordisk ( ($NVO) ) has fallen by -7.11%. Read on to learn why. Novo Nordisk shares slipped 7.11% over the past week as investors weighed the c......

J.P. Morgan analyst Richard Vosser maintained a Buy rating on Novo Nordisk today and set a price target of DKK350.00. According to TipRanks, Vosser......

Novamarine S.P.A. ( ($IT:NOVA) ) just unveiled an announcement. Novamarine reported a continued strong commercial performance for 2025, with prelim......